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We have observed the finding of a large, pedun-
culated infrarenal aortic mural thrombus (AMT)
associated with only trivial atherosclerotic plaque in
several patients presenting with peripheral large-ves-
sel embolism. We report herein 2 patients treated
successfully with a combination of catheter-directed
thrombolytic therapy and anticoagulation.
CASE REPORT
Case 1. An otherwise healthy 71-year-old woman
with no history of or risk factors for atherosclerotic disease
presented with abrupt onset left calf claudication and
intermittent rest pain. Examination revealed a pallid left
foot with absent pedal pulses; elsewhere, the pulse was
found to be normal. Laboratory study results were normal
except for a mildly elevated hemoglobin level of 16.0 g.
Arteriography demonstrated a 2-cm pedunculated throm-
bus in the infrarenal aorta (Fig 1, A) and a 1-cm popliteal
artery embolus (Fig 1, B), with no significant atheroscle-
rotic changes elsewhere. An infusion catheter was posi-
tioned in the popliteal embolus and urokinase therapy
(Abbott Labs, North Chicago, Ill), was initiated. After 12
hours, the popliteal lesion had lysed completely and pedal
pulses had returned, but the aortic lesion was unchanged.
The patient initially declined surgical removal of the aortic
lesion and was anticoagulated with heparin; on follow-up
ultrasonography and magnetic resonance imaging 5 days
later, no aortic thrombus was visible. She was treated with
warfarin for 6 months and aspirin thereafter and has
remained free of abnormality on duplex surveillance
through 54 months of follow-up. Initial hypercoagulabili-
ty profiles were normal; however, she was ultimately diag-
nosed with polycythemia vera.
Case 2. A 59-year-old female smoker with no other
atherosclerotic risk factors presented 6 weeks after sigmoid
colectomy for colon cancer with a 3-day history of intermit-
tent left foot rest pain. She had been hospitalized for
chemotherapy–related dehydration and granulocytopenic
colitis 1 week earlier. Examination revealed an ischemic left
foot with normal pulses except for absent left pedal pulses;
laboratory study results were normal. Arteriography showed
a 1.5-cm teardrop-shaped filling defect in the infrarenal aorta
(Fig 2, A) and a popliteal embolus. Because of her recent
surgery and complications, a minimally invasive approach
was strongly desired. Urokinase therapy was directed at the
aortic thrombus, and this lesion resolved within 12 hours
(Fig 2, B); however, further embolization was noted at the
popliteal and tibial level, necessitating repositioning of the
catheter in the popliteal artery and further thrombolysis.
Although this was successful, she developed massive colonic
bleeding presumed to be secondary to her recent colitis. This
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CASE REPORTS
persisted after cessation of urokinase infusion but was suc-
cessfully controlled with intra-arterial Pitressin infusion. No
further anticoagulation was used, and surgery was not 
necessary. No aortic or peripheral abnormalities were present
on duplex follow-up through 36 months.
DISCUSSION
Although microembolization of atheromatous
material from an aortic source is a fairly common
and well-recognized clinical entity, episodes of
thrombus macroembolism are usually attributed to a
cardiac source and occasionally to laminar thrombus
associated with aortic aneurysm. The arteriographic
finding of a large filling defect in the aorta consist-
ing primarily of thrombus and associated with no or
minimal atherosclerotic plaque is a rare phenome-
non, published experience being limited to a few
dozen cases. However, improved diagnostic modali-
ties, such as high-resolution computed tomography,
transesophageal echocardiography, and magnetic
resonance imaging, have led to increasing recogni-
tion of this entity, which is more common than pre-
viously appreciated.
In 1981, Williams et al1 described a 5-year expe-
rience at Johns Hopkins Hospital with 20 patients
with AMT who experienced 36 separate embolic
events. The authors noted that whereas previous
reports of similar phenomena had generally been
associated with heparin therapy, 13 of their 20
patients were not receiving heparin. Ten patients had
associated cardiac disease, and 7 had lower extremi-
ty thrombophlebitis. Lesions were primarily made
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Fig 1.  A, Pedunculated filling defect in infrarenal aorta. B, Embolic occlusion of distal popliteal
artery.
A B
up of platelet rich thrombus, and minimal or no ath-
erosclerotic changes were noted. The authors pro-
posed that thrombus forms in situ on injured
endothelium and that hypercoagulability plays an
important role. Direct surgical excision of the lesion
was recommended, though in 1 patient in this series
complete spontaneous resolution of the AMT was
observed with anticoagulation alone.
Machleder et al,2 reporting on 2 cases of AMT
observed over 20 years at UCLA (the University
of California at Los Angeles), emphasized the dis-
tinct nature of the thrombus as a separate entity
from atherosclerotic plaque. AMT was found in 95
of 10,671 autopsies at UCLA (0.9%), and in
approximately half of these cases the aorta was
aneurysmal. Seventeen percent of patients had evi-
dence of peripheral emboli, and coexisting lesions
in the infrarenal and thoracic aorta were noted in
9 specimens. The authors conclude that “aortic
mural thrombus may be the consequence of a
more generalized hypercoagulation or vascular
endothelium disorder” and also suggest that many
cases of cryptogenic embolus ascribed to cardiac
sources are in fact secondary to AMT.2
Two cases of macroembolization of free-
floating thrombus of the ascending aorta unassoci-
ated with atheromata have been reported; both
were treated surgically.3 One patient had systemic
lupus erythematosus; no hypercoagulability was
demonstrable in the second case. Transaortic 
surgical excision of the mural thrombus was advo-
cated by the authors.
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Fig 2.  A, Pedunculated mural thrombus arising from infrarenal aorta. B, Nearly complete res-
olution of filling defect after thrombolytic therapy.
A B
AMT with peripheral embolization has also been
described in the descending thoracic aorta. Of inter-
est, and reminiscent of our cases, were one report
involving a patient with recently resected colon can-
cer4 and another involving a patient with poly-
cythemia vera.5 Surgical treatment was successful in
both. Agolini et al6 reported another surgically
treated case of descending aorta AMT causing
splenic infarction in a 60-year-old man without an
identifiable hypercoagulable state, though the
patient had experienced axillary artery embolism 13
years previously from an unknown source.
Aldrich et al7 reported 2 cases of AMT of the
descending aorta. The first patient, a 70-year-old
man, presented 2 weeks after radical prostatectomy
for prostate cancer with abdominal pain and bowel
ischemia. Heparin therapy was used, but the AMT
was then embolized to the superior mesenteric
artery, and embolectomy and bowel resection were
required. The second patient, a 60-year-old woman
with no recent surgery, malignancy, or definable
hypercoagulability, presented with extensive em-
bolization to her kidneys, viscera, and lower extrem-
ities and underwent transthoracic transaortic
removal of the AMT with success.7
Perler et al8 reported on 2 young women, aged
28 and 34 years, with infrarenal AMT unassociated
with atherosclerosis. One patient was taking oral
contraceptives, and the other was being treated with
prednisone for Crohn’s disease; however, the hyper-
coagulability profile was normal in both patients.
Both underwent successful surgical treatment,
though the authors suggest a role for thrombolytic
therapy on the basis of their experience.
Hahn et al9 reported on 6 patients with AMT, 4
presenting with macroembolism. The other 2
patients had severe pancreatitis, and an incidental
finding of AMT of the retropancreatic aorta was
noted—a finding we have also observed on 2 occa-
sions in patients without peripheral embolism. Of
the 4 treated patients, AMT was at the infrarenal
level in 3 and at the aortic arch in 1. All were treat-
ed with embolectomy, 1 with adjunctive intraopera-
tive thrombolysis. None underwent surgical excision
of the AMT, and all were treated with warfarin. The
AMT resolved in 2 patients (at 3 weeks and 3
months); it persisted at 9 months and 1 year in the
others.
Most recently, Reber et al10 reported on 8
patients with peripheral embolization from AMT.
Four lesions were at the infrarenal, 3 at the descend-
ing, and at the ascending aorta. In contradistinction
to other reports, only 1 of the 8 patients had an
identified hypercoagulability (protein C deficiency),
whereas all had significant atherosclerosis risk fac-
tors. The thrombi were described as adherent to
“intimal erosions” or to “variable degrees of athero-
sclerotic plaque,” suggesting that some may have
been manifestations of exuberant atherosclerosis
rather than primary AMT. Patients were treated with
catheter aspiration of the embolus (6 cases) or surgi-
cal embolectomy (2 cases); this was followed by sur-
gical treatment of the primary lesion in 7 cases
(transaortic thrombectomy or thromboendarterec-
tomy in 6, graft replacement in 1). At a mean fol-
low-up of 13 months, no recurrent emboli occurred.
There is only 1 report on the use of primary
thrombolytic therapy for AMT. Intravenous tissue
plasminogen activator was used by Hausman et al11 for
a 10 × 40-mm to pedunculated thrombus of the aor-
tic arch that had previously caused mesenteric
embolism and infarction. Complete resolution was
noted by transesophageal echocardiography. However,
there are risks to thrombolysis, and massive embolism
has been reported with lytic therapy for cardiac 
thrombus.12
AMT is probably a manifestation of a transient or
persistent hypercoagulable state of varying etiology.
Transesophageal echocardiography has led to the
increasing recognition of proximal AMT in patients
with and without peripheral embolism,3,4,6,10,13-15
and the optimal treatment approach has yet to be
defined. Others have reported resolution of AMT of
the aortic arch with anticoagulant therapy,9,13 as was
noted in our case 1. We have also observed several
cases of incidentally diagnosed AMT without
embolization, with resolution of the lesion with
anticoagulation alone.
Given this and our experience with re-emboliza-
tion after thrombolytic therapy directed at the aortic
lesion in case 2, we now favor peripheral thrombol-
ysis only, with heparinization thereafter, followed by
warfarin therapy. Accelerated lysis of the primary
AMT may occur from establishment of a systemic
lytic with peripheral therapy, and given the high flow
volume in the patent aorta, catheter positioning near
the AMT is probably not helpful and may risk dis-
lodging an unstable thrombus. Others have report-
ed favorable results with direct aortic surgery, but
inasmuch as in many cases there is minimal underly-
ing aortic pathosis, eliminating the thrombus is real-
ly the main goal of treatment. Anticoagulation,
rather than removal of the primary thrombus, has
generally worked well with cardiac source emboli,
and AMT may behave similarly. Careful follow-up
with transesophageal echocardiography, high-
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resolution CT, or color duplex for infrarenal lesions
is critical. The risk of more serious consequences to
embolization exists for suprarenal AMT in compari-
son with infrarenal AMT, so a more aggressive pos-
ture might be warranted in these cases. Continued
refinement of endovascular techniques also holds
promise.
AMT is more common than has previously been
appreciated, and optimal treatment of incidentally
found lesions is unknown. In patients with AMT
who have experienced peripheral embolization,
thrombolytic therapy may have an important role.
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